NCDR CARE Registry Carotid Artery Revascularization and Endarterectomy Registry Carotid Artery Stenting Form v1.09
|
|
- Betty Randall
- 6 years ago
- Views:
Transcription
1 NCDR CARE Registry Carotid Artery Revascularization and Endarterectomy Registry Carotid Artery Stenting Fm v1.09 A. PARTICIPANT ADMINISTRATION Participant ID 1000 : Participant Name 1010 : Medicare Provider # 1015 : Participant NPI 1016 : B. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - No SSN 2031 Unique Pt. ID 2040 : (auto) Other ID 2045 : HIC 2046 : No HIC 2047 Date of Birth 2050 : / / Sex 2060 : Male Female Race 2070 : White Black/African American C. ADMISSION Asian Native Hawaiian/Pacific Islander American Indian/Alaskan Native Other Hispanic Ethnicity 2076 : No Admission Date 3000 : / / Patient Zip Code 3005 : No Zip 3006 Insurance Pays (choose all that apply) 3010 : Medicare Medicaid Commercial Military/VAMC Non-U.S. Insurance Self/None D. HISTORY AND RISK FACTORS GENERAL HISTORY AND RISK FACTORs (PREPROCEDURE) Height 4000 : cm Weight 4005 : kg Preprocedure Creatinine Level (most recent pri to procedure) 4011 : mg/dl Not Assessed 4010 Currently On Dialysis 4015 : No Tobacco Histy 4020 : Current Fmer Never Hypertension 4025 : No Dyslipidemia 4030 : No Peripheral Arterial Disease (PAD) 4035 : No Diabetes Mellitus 4040 : No Chronic Lung Disease 4045 : No If, Home O2 Therapy 4046 : No Maj Surgery Planned w/in Next 8 Wks 4050 : No If, Type of Surgery 4051 : Cardiac Vascular Other Previous Neck Radiation 4055 : No Pri Neck Surgery (other than CEA) 4060 : No Tracheostomy Present 4065 : No Previous Laryngeal Nerve Palsy 4070 : No -Right -Left CARDIAC HISTORY (PREPROCEDURE) Ischemic Heart Disease 4200 : No Histy of Atrial Fibrillation Flutter 4230 : No Two Me Maj Conary Arteries with >= 70% (LAD, LCX, RCA) 4202 : No Left Main Conary Artery >= 50% 4232 : No MI w/in 6 Weeks 4205 : No Moderate to Severe Atic 4235 : No Angina CCS Class III IV w/in 6 Weeks 4210 : No Moderate to Severe Mitral 4240 : No Histy of Heart Failure 4215 : No Mechanical Atic Mitral Valve 4245 : No NYHA Functional Class III IV w/in 6 Weeks 4220 : No Permanent Pacemaker ICD 4250 : No Most Recent LVEF % 4226 : Not Assessed 4225 ASA Grade 4255 : I II III IV V 2008 American College of Cardiology Foundation 7/19/2010 Page 1 of 6
2 Carotid Artery Stenting Fm v1.09 NEUROLOGIC HISTORY AND RISK FACTORS (PREPROCEDURE) Dementia Alzheimer s Disease 4300 : No Histy of Seizure Known Seizure Disder 4305 : No Previous Carotid Intervention 4310 : No If, select most recent occurrence f each: Carotid Artery Carotid Intervention No <= 30 days days >= 181 days Right CEA 4311 CAS 4312 Left CEA 4313 CAS 4314 Neurologic Event(s) pri to procedure 4320 : No If, select most recent occurrence f each: Categy Territy No Transient Ischemic Attack (resolved w/in 24 hours) Ischemic Stroke (completed) Intracranial Hemrhage Hemrhagic Stroke <= 30 days days >= 181 days Right Retinal 4321 Left Retinal 4322 Right Hemispheric 4323 Left Hemispheric 4324 Vertebrobasilar 4325 Unknown 4326 Right Retinal 4327 Left Retinal 4328 Right Hemispheric 4329 Left Hemispheric 4330 Vertebrobasilar 4331 Unknown 4332 Intraparenchymal 4333 Subarachnoid 4334 Subdural 4335 Acute Evolving Stroke (ongoing and progressing at the time of the procedure) 4340 : No NEUROLOGIC STATUS (PREPROCEDURE) Preprocedure NIH Stroke Scale Total Sce 4401 : Not Administered 4400 Date Administered 4402 : / / Examiner Name: Last 4405 : First 4406 : Middle 4407 : Certified 4404 : No Preprocedure Modified Rankin Sce 4411 : Not Administered 4410 NON-INVASIVE CAROTID STUDIES (PREPROCEDURE) Carotid Duplex Ultrasound 4500 : MR Angiography (MRA) Perfmed 4600 : CT Angiography (CTA) Perfmed 4700 : No No No If yes, If yes, enter highest values ranges If yes, enter highest values ranges Right Left Peak Systolic Velocity cm/sec 4505 cm/sec 4510 End Diastolic Velocity cm/sec 4515 cm/sec 4520 ICA/CCA Ratio CCA ICA CCA ICA 2008 American College of Cardiology Foundation 7/19/2010 Page 2 of 6 Right Highest % 4605 : Lower % 4610 : Upper % 4615 : Highest % 4635 : Lower % 4640 : Upper % 4645 : Right Highest % 4705 : Lower % 4710 : Upper % 4715 : Highest % 4735 : Lower % 4740 : Upper % 4745 : Left Highest % 4620 : Lower % 4625 : Upper % 4630 : Highest % 4650 : Lower % 4655 : Upper % 4660 : Left Highest % 4720 : Lower % 4725 : Upper % 4730 : Highest % 4750 : Lower % 4755 : Upper % 4760 :
3 Carotid Artery Stenting Fm v1.09 E. PROCEDURE INFORMATION Date of Procedure 5000 : / / Target Carotid Vessel 5005 : Right Left Operat s UPIN 5010 : Operat s NPI 5015 : Operat Name: Last 5020 : First 5021 : Middle 5022 : Current Procedure Part of a Carotid Clinical Trial 5025 : No If, Trial Type5026 : Postmarket Surveillance Premarket Approval IDE Other Anesthesia 5030 : General Local PROCEDURE INDICATIONS AND ANATOMIC VARIABLES Urgent Cardiac Surgery Needed w/in 30 days 5033 : No Contralateral Carotid Artery Occlusion 5050 : No Target Lesion Symptomatic w/in Past 6 Months 5035 : No Fibromuscular Dysplasia of Carotid Artery 5055 : No Restenosis in Target Vessel after pri CAS 5040 : No Spontaneous Carotid Artery Dissection 5060 : No Restenosis in Target Vessel after pri CEA 5045 : No Lesion Difficult to Access Surgically 5500 : No If, Lesion Location 5501 : High Cervical Low Intrathacic Atic Arch Type 5505 : Type I Type II Type III Bovine Arch 5515 : No Contrast Volume 5510 : ml Arterial Access Closure Method(s) 5532,5533 Fluo Time 5520 : minutes Procedural Arterial Access Site 5525 : Femal Brachial/Radial/Axillary Direct Carotid Puncture Carotid Cutdown Other F. LESIONS AND DEVICES (REPEAT SECTION FOR EACH LESION ATTEMPTED) Target Lesion Location 6000 : Isolated CCA Isolated ICA Bifurcation Visible Thrombus Present 6005 : No Ulceration 6010 : No Calcification 6015 : None Mild to Moderate Dense and Concentric Lesion Length 6020 : mm Minimum Luminal Diameter (MLD) 6025 : mm (list methods and/ devices in chronological der below) 2008 American College of Cardiology Foundation 7/19/2010 Page 3 of Diameter of Distal (Non-tapered) ICA f NASCET 6030 : mm Preprocedure % (use NASCET technique unless CCA) 6035 : % Lesion Treatment Incomplete Abted 6040 : No If, Reason 6041 : (Check all that apply below) Failure to gain vascular access Failure to confirm significant stenosis Unable to place guiding catheter/sheath Unable to cross guidewire Unable to cross balloon Unable to deploy EPD Unable to deliver stent Unable to deploy stent Difficult to access due to ttuosity Hypotension Hypertension Arrhythmia Cardiac ischemia Other Embolic Protection Attempted 6100 : No If, Predilation Pri to EPD Deployment 6101 : No If, (list EPD devices in chronological der below) 1 EPD Brand/Model 6114 /Manufacturer 6113 Successfully Deployed 6111 No 2 No Predilation Pri to Attempted Stent Implant (but after Embolic Protection Device) 6201 : No Stent(s) Implanted 6200 : No If, (list stents in chronological der below) Stent Brand/Model 6217 /Manufacturer Diameter6212 Tapered (smallest if tapered) Length 6213 Malposition No mm mm No 2 No mm mm No Postdilation Perfmed 6300 : No If, Nominal Balloon Diameter 6301 : If, Maximum Inflation Pressure 6302 : Final Minimum Luminal Diameter (MLD) 6305 : mm atm mm Final % (use NASCET technique unless CCA) 6310 : %
4 Carotid Artery Stenting Fm v1.09 G. MEDICATIONS Note: F each med indicate No (not administered), (administered) Contra (Contraindicated Blinded). PREPROCEDURE MEDICATIONS 7000,7001 Categy (Indicate the meds patient received in adequate dose to achieve a therapeutic level at the onset of the procedure.) Preprocedure Categy Preprocedure No Contra No Contra Antiplatelets ASA (Aspirin) Antiplatelets Prasugrel Clopidogrel (Plavix) Ticlopidine (Ticlid) INTRAPROCEDURE AND POSTPROCEDURE MEDICATIONS 7005,7010,7001 (Indicate the meds patient received intra and post procedure.) Categy Anticoagulants Unfractionated Intraprocedure Postprocedure Categy No Contra No Contra IIb/IIIas Intraprocedure Postprocedure No Contra No Contra Heparin LMWH Vasodilats Any Atropine Atropine Vasopresss Any Thrombin Inhibits Any H. POSTPROCEDURE NEUROLOGIC ASSESSMENT (RECOMMENDED TIMEFRAME IS 24 HRS POSTPROCEDURE) Postprocedure NIH Stroke Scale Total Sce 7101 : Not Administered 7100 Date Administered 7102 : / / Examiner Name: Last 7105 : First 7106 : Middle 7107 : Certified 7104 : No Postprocedure Modified Rankin Sce 7111 : Not Administered 7110 I. ADVERSE EVENTS (DURING HOSPITALIZATION FOR CURRENT PROCEDURE) Any New Stroke TIA 7200 : No If, Specify All New Events and Resolution Status below: Territy No New Deficit Developed? - Intra - Post Procedure Procedure - Intra Procedure Deficit Resolved? - W/in 24 hrs of Procedure - Befe Discharge Right Hemispheric Retinal 7205, 7210 If Left Hemispheric Retinal 7215, 7220 If Vertebrobasilar 7225, 7230 If Unknown 7235, 7240 If Other Adverse Events 7300 : No If, Specify All Other Adverse Events 7304,7305 below: Not Resolved Categy Description No Categy Description No Other Neurologic (not TIA/ Stroke) Cardiac and Hemodynamic New Seizure (intra post) Angiographic Unanticipated Carotid Tear Dissection Requiring Treatment Hyperperfusion Syndrome Urgent Surgery Required f Technical Problems with Stent Deployment Persistent Hypotension Requiring Treatment with Parenteral s >24 Hours Post-Procedure Placement Intracranial Hemrhage Intracranial Embolization Bleeding Procedure Related Bleeding Hematoma Requiring Red Blood Cell Transfusion Arrhythmia Requiring Cardioversion, Implantation of a Permanent Pacer ICD Arterial Access Site Pseudoaneurysm Requiring Treatment w/thrombin Injection and/ Compression During Hospitalization Myocardial Infarction Access Site Related Injury requiring open Acute Heart Failure Pulmonary Edema surgical repair Vessel Thrombosis, Peripheral Embolization New Ischemia of Extremity Renal New Requirement f Dialysis Other Unexpected Intubation and/ Resuscitation Infection Contrast Reaction (anaphylactoid type) Infection Related to Procedure, Requiring Antibiotics 2008 American College of Cardiology Foundation 7/19/2010 Page 4 of 6
5 Carotid Artery Stenting Fm v1.09 J. DISCHARGE Peak Postprocedure Creatinine Level (obtained pri to discharge) 8001 : mg/dl Not Assessed 8000 Discharge Date 8005 : / / Discharge Status 8010 : Alive Deceased If Deceased, Cause of Death 8011 : Neurologic Cardiac Pulmonary Vascular Infection Renal Other If Deceased, Death During Procedure 8012 : No If Alive DISCHARGE MEDICATIONS 8020,7001 (Indicate the meds that were prescribed at discharge.) Categy Anticoagulants Antiplatelets Warfarin Prescribed at Discharge Prescribed at Discharge Categy No Contra No Contra (Coumadin) Statins Any ASA (Aspirin) Other Lipid Lowering Agent (non-statin) Any Clopidogrel (Plavix) Ticlopidine (Ticlid) Prasugrel If Alive Anticipated Follow-up Date 8025 : / / 2008 American College of Cardiology Foundation 11/21/2008 Page 5 of 6
6 NCDR CARE Registry Carotid Artery Revascularization and Endarterectomy Registry Carotid Artery Stenting Follow-Up Fm v1.09 K. FOLLOW-UP (RECOMMENDED TIMEFRAME IS 30 DAYS) PARTICIPANT INFORMATION: Participant ID 1000 : Participant Name 1010 : PATIENT INFORMATION: Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - No SSN 2031 Date of Birth 2050 : / / Date of Procedure 5000 : / / Target Carotid Vessel 5005 : Right Left Patient Follow-up Perfmed 9000 : No If No, Why Was Follow-up Not Perfmed 9001 : Patient Refused Patient Unavailable Other If, Complete Below: Follow-up Date 9002 : / / Follow-up NIH Stroke Scale Total Sce 9011 : Not Administered 9010 Date Administered 9012 : / / Examiner Name: Last 9015 : First 9016 : Middle 9017 : Certified 9014 : No Follow-up Modified Rankin Sce 9021 : Not Administered 9020 Additional CEA on Target Carotid Vessel 9030 : No Additional CAS on Target Carotid Vessel 9035 : No If the patient has not been discharged at the time of follow-up, do not collect the remaining elements on this fm. Patient Status 9100 : Alive Deceased If Deceased, Date of Death 9101 : / / If Deceased, Cause of Death at Follow-Up 9102 : Neurologic Cardiac Pulmonary Vascular Infection Renal Other If Alive, Complete the Following: Neurologic Deficit(s) Occurred Since Discharge 9110 : No If, Indicate Territies and Timeframes below: Territy No Deficit Occurred Deficit Occurrence and Resolution Timeframe Deficit Occurred, Deficit Occurred, Resolved Duration >24 hours, But w/in 24 hours (i.e. TIA) Completely Resolved Persistent Deficit Occurred Lasting > 24 Hours, Not Completely Resolved Right Retinal 9111 Left Retinal 9112 Right Hemispheric 9113 Left Hemispheric 9114 Vertebrobasilar 9115 Unknown 9116 OTHER EVENTS SINCE DISCHARGE: If Alive Myocardial Infarction Since Discharge 9150 : No If Alive Renal Failure Requiring Dialysis 9165 : No If Alive Most Recent Creatinine Level (obtained since discharge) 9171 : mg/dl If Alive Not Assessed American College of Cardiology Foundation 7/19/2010 Page 6 of 6
NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry
A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : *** @ Sex 2060 : *** @ O Male O Female Race:
More informationCarotid Artery Stenting
Carotid Artery Stenting JESSICA MITCHELL, ACNP CENTRAL ILLINOIS RADIOLOGICAL ASSOCIATES External Carotid Artery (ECA) can easily be identified from Internal Carotid Artery (ICA) by noticing the branches.
More informationCarotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO
Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control
More informationNew Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)
A. ADMINISTRATIVE New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) 1. Facility Code: 2. Facility Name: 3. Procedure Type (Choose only
More informationCarotid Revascularization
Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical
More informationNew Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008
New Trials in Progress: ACT 1 Jon Matsumura, MD Cannes, France June 28, 2008 Faculty Disclosure I disclose the following financial relationships: Consultant, CAS training director, and/or research grants
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33200-37186, 37195-37785, 92950-93272, 93303-93581,
More informationPost-op Carotid Complications A Nursing Perspective of What to Watch Out for
Post-op Carotid Complications A Nursing Perspective of What to Watch Out for By Kariss Peterson, ARNP Swedish Medical Center Inpatient Neurology Team 1 Post-op Carotid Management Objectives Review the
More informationTreatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery
Treatment Considerations for Carotid Artery Stenosis Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery 4.29.2016 There is no actual or potential conflict of interest in regards to this presentation
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,
More informationCarotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014
Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost
More information(auto) à If Yes, Most Recent LVEF Date 4155 : à If Yes, Most Recent LVEF 4160 :
A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : Sex 2060 : O Male O Female Patient Zip Code
More informationNCDR PVI Registry (Peripheral Vascular Intervention Registry) v 2 Renal Artery Intervention Module- DRAFT ,,, Patient Restriction N683
Page 1 of 12 A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : Birth Date 2050 : Sex 2060 : O Male Race: (check all that apply) B. EPISODE
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital
More informationCEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
More informationCurrent Non-Surgical Cardiac Interventions. By Pam Bayles, RN, BSN
Current Non-Surgical Cardiac Interventions By Pam Bayles, RN, BSN Balloon Angioplasty & DES A balloon-tipped catheter was first used in 1964 to treat a cause of atherosclerotic disease in a patient s leg
More informationREBEL. Platinum Chromium Coronary Stent System. Patient Information Guide
REBEL Patient Information Guide REBEL PATIENT INFORMATION GUIDE You have recently had a REBEL bare metal stent implanted in the coronary arteries of your heart. The following information is important for
More informationUPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?
UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? Richard W. Petrella M.D. FACP,FACC,FASCI DEPARTMENT CHAIRMAN CVM&S UPMC HAMOT MEDICAL CENTER 1 LEARNING OBJECTIVES REVIEW THE RISK FACTORS FOR
More informationCarotid Stenosis 1/24/2019. Review of Primary Studies. NASCET- Moderate stenosis. ACAS (Asymptomatic Carotid Atherosclerosis Study) NASCET
Review of Primary Studies Carotid Stenosis NINDS National Institute of Neurological Disorders and Stroke 2 large studies to determine who would benefit from surgery NASCET North American Symptomatic Carotid
More informationRecanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion
Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Paul Hsien-Li Kao, MD Assistant Professor National Taiwan University Medical School and Hospital ICA stenting
More informationTRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES
TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES ALBERTO MAUD, MD ASSOCIATE PROFESSOR TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER EL PASO PAUL L. FOSTER SCHOOL OF MEDICINE 18TH ANNUAL RIO GRANDE TRAUMA 2017
More informationPrevention and Management of Cardiac Adverse Event
Prevention and Management of Cardiac Adverse Event Carlo Cernetti Department of Interventional Cardiology Mirano (Italy) Cannes MEEC 14 June 2007 Are these risks factors of Haemodynamic Instability
More informationIndex. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACAS (Asymptomatic Carotid Atherosclerosis Study), 65 66 ACST (Asymptomatic Carotid Surgery Trial), 6 7, 65, 75 Age factors, in carotid
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationPrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!!
PrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!! Prof Piotr Pieniazek MD PhD Jagiellonian University Institute of Cardiology, John Paul II Hospital Krakow, Poland
More informationCarotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA
Carotid Artery Stenting (CAS) Carotid Artery Stenting for Stroke Risk Reduction Matthew A. Corriere MD, MS, RPVI Assistant Professor of Surgery Department of Vascular and Endovascular Surgery Rationale:
More information2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics
NCDR.13 Case Scenario Presentation Cath PCI Registry Dashboard Implications of Some Major Metrics Disclosures Tony Hermann has nothing to disclose Mark Hutcheson has nothing to disclose Cornelia Anderson
More informationAssessment of the procedural etiology of stroke resulting from carotid artery stenting
Assessment of the procedural etiology of stroke resulting from carotid artery stenting 1. Study Purpose and Rationale: A. Background Stroke is the 3 rd leading cause of death in the United States and carries
More informationVivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine
Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,
More informationCarotid Artery Stenting
Carotid Artery Stenting Woong Chol Kang M.D. Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Carotid Stenosis and Stroke ~25% of stroke is due to carotid disease, the reminder
More informationCAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough
Todd W GenslerMD April 28, 2018 CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough DISCLOSURES I have no financial disclosures Presenter name
More informationNCDR AFib Ablation Registry v1.0 Atrial Fibrillation (AF) Ablation Interventional Registry
A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : Sex 2060 : O Male O Female Patient Zip Code
More informationNCVD-PCI Registry. Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association of Malaysia
NCVD-PCI Registry National Cardiovascular Disease Database (NCVD) National Cardiovascular Disease Database (NCVD) Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association
More informationMichael Horowitz, MD Pittsburgh, PA
Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion
More informationTAVR : Caring for your patients before and after TAVR
TAVR : Caring for your patients before and after TAVR Zubair Ahmed MD FSCAI Interventional Cardiologist Washington Regional Medical Center / Walker Heart Institute What is Aortic Valve Stenosis? AVA ~4
More informationOctogenarians Must Be Treated With CAS
Some Octogenarians Must Be Treated With CAS LN Hopkins, MD E Levy MD, Adnan Siddiqui,, MD, PhD Rod Samuelson MD J Mocco MD LN Hopkins, MD Potential Conflicts Consultant & research support: Boston Scientific,
More informationSupplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
More informationQuality Measures MIPS CV Specific
Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from
More informationCarotid Artery Stenting
Carotid Artery Stenting Natural history of the carotid stenosis Asymptomatic 80% carotid stenosis - 6% risk of stroke / year Symptomatic carotid stenosis have 10% risk of CVA at one year and 40% at 5 years
More informationGWTG Post-Discharge Follow-up Form
Bold font = Required field Patient ID: Date of Hospital Admission: / / mm / dd / yyyy Date Follow-up Completed: / / mm / dd / yyyy PATIENT LOGISTICS Method used for Patient follow-up: Chart Review Health
More informationPatient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /
Patient Patient code Birth date: / / Sex: Male Height (cm): Female Weight (kg): Risk Factors: Family history of coronary disease: Hypertension Dyslipidemia Peripheral disease Diabetes Comorbidities: No
More information(For items 1-12, each question specifies mark one or mark all that apply.)
Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationVersion 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM
Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationPre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease
Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Michael R. Jaff, D.O., F.A.C.P., F.A.C.C. Assistant Professor of Medicine Harvard Medical School Director, Vascular Medicine
More informationAsif Serajian DO FACC FSCAI
Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac
More informationPeter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI
Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Director, Peripheral Vascular Interventional Laboratory Director, Vascular & Endovascular Medicine Fellowship Program Assistant Professor of Medicine The
More informationContemporary Management of Carotid Disease What We Know So Far
Contemporary Management of Carotid Disease What We Know So Far Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Disclosers NONE Epidemiology 80 % of stroke are
More informationAlex versus Xience Registry Preliminary report
Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor
More informationHypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis
Cryoplasty or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments Background: Diabetes mellitus is associated with increased risk of in-stent restenosis
More informationCarotid Revascularization Immediately Before Urgent Cardiac Surgery
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 11, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.09.010 Carotid Revascularization
More informationSubclavian artery Stenting
Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence
More informationContinuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
More informationYes No Unknown. Major Infection Information
Rehospitalization Intervention Check any that occurred during this hospitalization. Pacemaker without ICD ICD Atrial arrhythmia ablation Ventricular arrhythmia ablation Cardioversion CABG (coronary artery
More informationAre Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &
Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) & Biomatrix TM Single Center Experience (Indonesia)(Final 5 Yr F up) T. Santoso University of
More informationShawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists
Shawke A. Soueidan, MD Riverside Neurology & Sleep Specialists 757-221-0110 Epidemiology of stroke 2018 Affects nearly 800,000 people in the US annually Approximately 600000 first-ever strokes and 185000
More informationDisclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease
Disclosures Your Patient Has Carotid Bulb Stenosis and a Tandem Intracranial Stenosis: How Do SAMMPRIS and Other Evidence Inform Your Treatment? UCSF Vascular Symposium 2015 Steven W. Hetts, MD Associate
More informationCarotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery
2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1
More informationTransient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction
Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) Copyright: CPT only 2006 American Medical Association (or such other date of publication of CPT). All
More informationExtracranial Carotid Artery Stenting With or Without Distal Protection Device
Extracranial Carotid Artery Stenting With or Without Distal Protection Device Eak-Kyun Shin MD. Professor of Medicine Division of Cardiology, Heart Center, Gil Medical Center Gacheon Medical School Incheon,
More informationCerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009
Cerebrovascular Disease RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease Stroke is the 3 rd leading cause of death and the leading
More informationDr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre
Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Objectives To learn what s new in stroke care 2010-11 1) Acute stroke management Carotid artery stenting versus surgery for symptomatic
More informationCAROTID ARTERY ANGIOPLASTY
CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline
More informationCarotid Artery Stent: Is it ready for prime time?
2010 CATH LAB SYMPOSIUM Carotid Artery Stent: Is it ready for prime time? Luis F. Tami, MD, FACC, FSCAI Interventional Cardiology and Vascular Medicine Memorial Regional Hospital August 2010 CAE and CAS
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationThe CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent
The CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent 6 month data Piotr Musialek, MD DPhil FESC Jagiellonian University Dept. of Cardiac & Vascular Diseases John
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationInternal Carotid Artery Dissection
May 2011 Internal Carotid Artery Dissection Carolyn April, HMS IV Agenda Presentation of a clinical case Discussion of the clinical features of ICA dissection Discussion of the imaging modalities used
More information/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis
Multi-Ethnic Study of Atherosclerosis Participant ID: Hospital Code: Hospital Abstraction: Stroke/TIA History and Hospital Record 1. Was the participant hospitalized as an immediate consequence of this
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationSheffield guidelines for the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017)
Sheffield guidelines f the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017) Approved by Sheffield Area Prescribing Committee and Sheffield Teaching Hospitals
More informationàif Yes, Most Recent AV Procedure Date 4065 : àif Yes, AV Replacement Surgical 4070 : àif Yes, AV Model ID 4078 : àif Yes, AV Repair Surgical 4080 :
A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : Race: (check all that apply) B. EPISODE OF CARE
More informationChapter 4 Section 9.1
Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) Copyright: CPT only 2006 American Medical Association (or such other date of publication of CPT). All
More informationCardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai
CardioLucca2014 Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee Fabrizio Tomai European Hospital e Aurelia Hospital Roma Treatment of Carotid Artery Disease
More informationa physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers
The study a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers Conflict of interest have the following potential conflicts of interest to report: Consulting
More information2015 Update in Diagnosis and Management of Stroke
2015 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive Vice Chair, Department
More information2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction Developed in Collaboration with American College of Emergency Physicians and Society for Cardiovascular Angiography and
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationTiming of Surgery After Percutaneous Coronary Intervention
Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More informationCoronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Introduction This Clinician Guide is based on the 2017 KP National Coronary Artery Disease
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More informationFast-track CEA: a 3-year experience
Fast-track CEA: a 3-year experience Giorgio L. Poletto, MD Milano, Italy 6th ACST-2 Collaborators Meeting, Palau de Congresos, Valencia. 24th and 25th September 2018. Stroke prevention Primary prevention:
More informationGuiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology
Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology Ann M. Leonhardt Caprio, MS, RN, ANP-BC Program Coordinator Comprehensive Stroke Center, Strong Memorial Hospital Clinical
More informationCarotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015
Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015 John L. Crawford, MD, FACS Neuroscience Summit 2015 UNT Health Sciences Center September 12, 2015 www.cdc.gov/datastatistics2013
More informationTable S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture
Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX
More informationCarotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis William A. Gray MD System Chief of Cardiovascular Services, President, Wynnewood, PA USA Two parallel multi-center randomized,
More informationAssurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM
Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM Innovating for life. CONFORMABILIT Y 6 F S H E AT H C O M PAT I B I L I T Y THE ASSURANT COBALT ILIAC STENT, WITH ITS UNIQUE COBALT CHROMIUM MODULAR
More informationPreoperative Management of Patients Receiving Antithrombotics
Preoperative Management of Patients Receiving Antithrombotics Bleeding complications remain an important concern for most surgical procedures. Attempts to minimize the risk of these complications by removing
More informationManagement of combined coronary & carotid disease
Management of combined coronary & carotid disease Combined Carotid and coronary artery diseases Frequent combination Fear of imminent death psychologically traumatic for the patients and their families
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationWhat is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?
What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,
More informationFFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria
FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria I would like to express my personal gratitude to Dr. BK Koo for opening
More information